日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Ficolin-3 Activates Complement and Triggers Necroptosis in Cholangiocarcinoma Cells via the RIPK1/RIPK3/MLKL Signaling Pathway

Ficolin-3 通过 RIPK1/RIPK3/MLKL 信号通路激活补体并触发胆管癌细胞坏死

期刊:FASEB Journal
影响因子:4.2
doi:10.1096/fj.202403313R
Zhang, Zeyu; Yin, Maopeng; Geng, Xueyan; Zhao, Hongxi; Zhang, Shoucai; Liu, Yingjie; Liang, Yongyuan; Ji, Jian; Zheng, Guixi
RIPK3
肿瘤
肿瘤免疫
信号转导
MLKL
胆管癌
细胞生物学
RIP
毒理研究
免疫/内分泌
发表日期：2025
文献求助 收藏

Development of a diagnostic model for ovarian cancer based on machine learning algorithms and functional analysis of key biomarker SOX17.

基于机器学习算法和关键生物标志物SOX17功能分析的卵巢癌诊断模型的开发。

期刊:Journal of Ovarian Research
影响因子:4.2
doi:10.1186/s13048-025-01809-w
Geng Xueyan, Yin Maopeng, Zhao Hongxi, Zhang Zeyu, Liu Shichao, Liu Yingjie, Zhang Shoucai, Liang Yongyuan, Song Li, Zheng Guixi
肿瘤
SOX
肿瘤免疫
卵巢癌
发表日期：2025
文献求助 收藏

Establishment and validation of a diagnostic model for cholangiocarcinoma based on LightGBM machine-learning algorithm

基于LightGBM机器学习算法的胆管癌诊断模型的建立与验证

期刊:Scientific Reports
影响因子:3.9
doi:10.1038/s41598-025-30431-5
Zhang, Zeyu; Geng, Xueyan; Yin, Maopeng; Liang, Yongyuan; Zheng, Guixi
肿瘤
胆管癌
肿瘤免疫
发表日期：2025
文献求助 收藏

A Novel Prognostic Signature Integrating Immune and Glycolytic Pathways for Enhanced Prognosis and Immunotherapy Prediction in Hepatocellular Carcinoma.

一种整合免疫和糖酵解途径的新型预后特征，用于增强肝细胞癌的预后和免疫治疗预测

期刊:Journal of Hepatocellular Carcinoma
影响因子:3.4
doi:10.2147/JHC.S510460
Zhang Zeyu, Zhao Hongxi, Wang Pengyu, Geng Xueyan, Yin Maopeng, Liu Yingjie, Zhang Shoucai, Liang Yongyuan, Ji Jian, Zheng Guixi
细胞生物学
肿瘤免疫
发表日期：2025
文献求助 收藏

Unveiling ficolins: diagnostic and prognostic biomarkers linked to the Tumor Microenvironment in Lung Cancer

揭示纤维蛋白聚糖：与肺癌肿瘤微环境相关的诊断和预后生物标志物

期刊:World Journal of Surgical Oncology
影响因子:2.5
doi:10.1186/s12957-024-03558-4
Zhang, Zeyu; Geng, Xueyan; Yin, Maopeng; Zhang, Shoucai; Liu, Yingjie; Hu, Dongmei; Zheng, Guixi
肺癌
肿瘤
肿瘤微环境
肿瘤免疫
发表日期：2024
文献求助 收藏